FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/01/061424 [Registered on: 12/01/2024] Trial Registered Prospectively
Last Modified On: 02/01/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Beneficial effects of zinc supplementation in adults suffering from acute diarrhea 
Scientific Title of Study   Role of zinc in adults with acute diarrhea: A randomized controlled trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Sriram Reddy VM 
Designation  PG Resident 
Affiliation  UCMS and GTB Hospital 
Address  Department of Medicine UCMS and GTB Hospital Dilshad gardens Delhi
2, Tahirpur Rd, GTB Enclave, Dilshad Garden, New Delhi, Delhi, 110095
North East
DELHI
110095
India 
Phone  7013356606  
Fax    
Email  vmsr.245@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Kuldeep Kumar 
Designation  Associate Professor 
Affiliation  UCMS and GTB Hospital 
Address  Department of Medicine UCMS and GTB Hospital Delhi- 110095
2, Tahirpur Rd, GTB Enclave, Dilshad Garden, New Delhi, Delhi, 110095
North East
DELHI
110095
India 
Phone  9891043711  
Fax    
Email  drkuldeep74@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Kuldeep Kumar 
Designation  Associate Professor 
Affiliation  UCMS and GTB Hospital 
Address  Department of Medicine UCMS and GTB Hospital Delhi- 110095
2, Tahirpur Rd, GTB Enclave, Dilshad Garden, New Delhi, Delhi, 110095
North East
DELHI
110095
India 
Phone  9891043711  
Fax    
Email  drkuldeep74@gmail.com  
 
Source of Monetary or Material Support  
UCMS and GTB Hospital, Delhi- 110095 
 
Primary Sponsor  
Name  Sriram Reddy VM 
Address  PG Resident, Department of Medicine, UCMS and GTB Hospital, Delhi - 110095 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sriram Reddy V M  UCMS and GTB Hospital  Ward No 16,17,26,27,CCU,259B,53. Department of Medicine 2, Tahirpur Rd, GTB Enclave, Dilshad Garden, Delhi 110095
North East
DELHI 
7013356606

vmsr.245@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee- Human research, University college of medical sciences, University of Delhi, Delhi-110095  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: R197||Diarrhea, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  NIL  Patients in the control group get standard treatment for diarrhea without zinc supplementation 
Intervention  Zinc supplementation  Patients in the intervention group will get zinc supplementation with Tablet Zinc Sulfate 50mg along with the normal standard treatment for diarrhea until the diarrhea resolves.Tablet Zinc sulphate 50mg will be given till the patient has loose stools of frequencyless than or equal to 3 per day marking the resolution of diarrhea or upto 14 days which ever is the earliest. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  Any patient of age more than or equal to 18 with acute diarrhea ( Diarrhea lasting for less than or equal to 14 days) 
 
ExclusionCriteria 
Details  1. Known cases of Inflammatory bowel disease, irritable bowel syndrome, celiac disease or any other known causes of malabsorption syndromes.
2. Patients who are on immunosuppressant therapy, cancer chemotherapy and radiotherapy
3. Known cases of HIV.
4. Patients on laxatives.
5. Patients with history of bowel resection or other major bowel surgeries
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
The difference in the proportion of the patients with resolution of diarrhea by day 5 in the intervention group compared to the control group.  Day 5 of recruitment 
 
Secondary Outcome  
Outcome  TimePoints 
The proportion of patients developing complications in the intervention group compared to the control group.  From day of recruitment till day of discharge 
 
Target Sample Size   Total Sample Size="142"
Sample Size from India="142" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   12/01/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

SUMMARY OF PROTOCOL

 

Research question: Does zinc play a role on the course of acute diarrhea in adult patients?

 

Study title: Role of zinc in adults with acute diarrhea: A randomized controlled trial

 

Rationale: Use of zinc in children with acute diarrhea is well established with WHO recommending zinc supplementation as an adjunct to the standard ORS. Research about the use of zinc in adult diarrhea is scarce. As zinc is a cost-effective supplement with a well-established use in children, this study is being done if zinc supplementation during the course of diarrhea will benefit the adult patient as much as it does in children.

 

Aim: To study the role of zinc supplementation in adults suffering from acute diarrhea

 

Objectives

Primary objective:

To find out the difference in the proportion of the patients with resolution of diarrhea by day 5.

 

Secondary objective:

To find out the proportion of patients developing complications of acute diarrhea in the treatment and the control groups.

Setting: The study will be conducted on patients visiting Medicine Emergency and Medicine wards University College of Medical Sciences and GTB Hospital, Delhi.

 

Study design: Open-label Randomized Controlled Trial

 

Time Frame: May 2023 to October 2024

 

Participants: Adult patients (≥ 18 years) coming to Medicine emergency and getting admitted in medicine wards with Acute diarrhea (diarrhea lasting for upto 14 days).

 

Inclusion criteria for cases

·       Any patient aged  ≥18 years presenting with acute diarrhea (diarrhea lasting for  â‰¤ 14 days)

Exclusion Criteria for cases

·       Known cases of Inflammatory bowel disease, irritable bowel syndrome, celiac disease or any other known causes of malabsorption syndromes.

·       Patients who are on immunosuppressant therapy, cancer chemotherapy and radiotherapy

·       Known cases of HIV.

·       Any patients on laxatives.

·       Patients with history of bowel resection or other major bowel surgeries

 

 

 

 

 

 

 

 

METHODS

All patients who give consent for the study and who satisfy the inclusion and exclusion criteria will be considered for the study. Randomization and allotment concealment will be done. Sequentially numbered opaque sealed envelopes will contain the code of medication to be given to the participant. All the patients will receive standard care including ORS, iv fluids and antibiotics and the patient in the test group will receive tab zinc sulphate with 50 mg elemental zinc in addition. All the drugs used will be from the hospital pharmacy.

Detailed clinical history, examination and investigations will be carried out as per the case record sheet (chief complaints, history of presenting complaints, general physical examination, systemic examination and routine investigations). Serial blood investigations will be done in patients developing complications to monitor their progression and resolution. Investigations like stool and urine examinations will be conducted according to the suspected etiology..

OUTCOME MEASURES:

Primary outcome measures:
The difference in the proportion of the patients with resolution of diarrhea by day 5 in the intervention group compared to the control group.
Secondary outcome measures:
The proportion of patients developing complications in the intervention group compared to the control group.

Sample size:

Sample size calculation was done using the formula for sample size calculation for comparing proportions(1)

n = (Zα/2 + Zβ)2 * (p1(1 - p1) + p2 (1 - p2)) / (p1 - p2)2

In order to estimate a 10% difference between the group of patients receiving zinc supplementation and the placebo group suffering from diarrhea and expecting that 100% of patients receiving Zinc supplement recover by day 5, with type 1 error of 5% and power of 80, the sample size was calculated to be 77 in each group totaling to 154 for the study.

 

Statistical analysis:

·       The difference in the proportion of recovery rate between the two groups will be compared by Chi-square test.

·       Intention to treat principle will be applied for the comparison of the outcome between the two groups

·       In case of missing values due to loss to follow up and we were not able to get the information about the outcome in spite of our best effort, we will impute the missing outcome value by randomly selecting one of two possible outcomes defined in the study.

P value <0.05 will be considered significant. 
Close